• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma.

作者信息

Trubiano Jason A, George Anupkumar, Barnett Jennifer, Siwan Mahendra, Heriot Alexander, Prince H Miles, Slavin Monica A, Teh Benjamin W

机构信息

Department of Infectious Diseases, Peter MacCallum Cancer Centre , East Melbourne, Victoria , Australia.

出版信息

Leuk Lymphoma. 2015 Feb;56(2):512-4. doi: 10.3109/10428194.2014.920503. Epub 2014 Jul 15.

DOI:10.3109/10428194.2014.920503
PMID:24828871
Abstract
摘要

相似文献

1
A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma.一种不同类型的“同种异体移植”:成功的粪便微生物群移植治疗复发侵袭性B细胞淋巴瘤患者的复发性难治性艰难梭菌感染
Leuk Lymphoma. 2015 Feb;56(2):512-4. doi: 10.3109/10428194.2014.920503. Epub 2014 Jul 15.
2
First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe.冷冻封装粪便微生物群移植首次用于复发性艰难梭菌感染,并在欧洲投入临床实践。
Clin Microbiol Infect. 2015 Nov;21(11):e82-4. doi: 10.1016/j.cmi.2015.06.027. Epub 2015 Jul 8.
3
Fecal microbiota transplant for C. difficile infection: Just say yes.粪便微生物移植治疗艰难梭菌感染:就是这么简单。
Anaerobe. 2019 Dec;60:102109. doi: 10.1016/j.anaerobe.2019.102109. Epub 2019 Oct 20.
4
Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection.商业化的粪便微生物群移植为艰难梭菌感染提供了有效的治疗方法。
Infect Dis (Lond). 2018 Nov-Dec;50(11-12):864-867. doi: 10.1080/23744235.2018.1500709. Epub 2018 Sep 28.
5
[Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].[粪便微生物群移植治疗复发性艰难梭菌感染:一例报告]
Rev Med Brux. 2016;37(3):174-177.
6
Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature.实体器官移植患者复发性艰难梭菌感染的粪便微生物群移植:机构经验及文献综述
Transpl Infect Dis. 2018 Dec;20(6):e12967. doi: 10.1111/tid.12967. Epub 2018 Jul 31.
7
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.粪便微生物群移植治疗合并炎症性肠病的复发性艰难梭菌感染患者
Rev Esp Enferm Dig. 2017 Jun;109(6):473-476. doi: 10.17235/reed.2017.4819/2016.
8
Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections.粪便微生物群移植作为暴发性艰难梭菌感染的挽救疗法。
Int J Antimicrob Agents. 2015 Aug;46(2):227-8. doi: 10.1016/j.ijantimicag.2015.05.002. Epub 2015 Jun 3.
9
[Refractory colitis by Clostridium difficile treated with fecal microbiota transplant].[艰难梭菌所致难治性结肠炎经粪便微生物群移植治疗]
Medicina (B Aires). 2019;79(4):291-294.
10
Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?粪便微生物群移植是艰难梭菌感染治疗的临时补救措施还是治疗学的新前沿?
Expert Rev Gastroenterol Hepatol. 2018 May;12(5):435-438. doi: 10.1080/17474124.2018.1465818. Epub 2018 Apr 20.

引用本文的文献

1
Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies.粪便微生物群移植的不良事件:高质量研究的荟萃分析。
Ann Gastroenterol. 2021 Nov-Dec;34(6):802-814. doi: 10.20524/aog.2021.0655. Epub 2021 Jul 2.
2
Emerging Roles for the Gut Microbiome in Lymphoid Neoplasms.肠道微生物群在淋巴瘤中的新作用
Clin Med Insights Oncol. 2021 Jun 17;15:11795549211024197. doi: 10.1177/11795549211024197. eCollection 2021.
3
Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.
造血干细胞移植和血液恶性肿瘤患者中的艰难梭菌感染。
Infect Dis Clin North Am. 2019 Jun;33(2):447-466. doi: 10.1016/j.idc.2019.02.010.
4
Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients.免疫功能低下患者粪便微生物群移植效用的临床综述
Curr Gastroenterol Rep. 2019 Feb 28;21(4):8. doi: 10.1007/s11894-019-0677-6.
5
Fecal microbiota transplantation in cancer management: Current status and perspectives.粪便微生物群移植在癌症管理中的应用:现状与展望。
Int J Cancer. 2019 Oct 15;145(8):2021-2031. doi: 10.1002/ijc.32003. Epub 2018 Dec 30.
6
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Infection in Immunocompromised Patients.免疫功能低下患者感染粪菌移植的疗效和安全性的系统评价。
Can J Gastroenterol Hepatol. 2018 Sep 2;2018:1394379. doi: 10.1155/2018/1394379. eCollection 2018.
7
Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.癌症患者艰难梭菌感染的风险因素及结局:一项配对病例对照研究。
Support Care Cancer. 2017 Jun;25(6):1923-1930. doi: 10.1007/s00520-017-3606-y. Epub 2017 Feb 2.
8
Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.干细胞移植患者中使用益生元和益生菌进行微生物群调控
Curr Hematol Malig Rep. 2016 Feb;11(1):19-28. doi: 10.1007/s11899-016-0302-9.
9
Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.粪便微生物群移植试验报告的最低要求
Middle East J Dig Dis. 2015 Jul;7:177-80.